Does being on finasteride effect HoLEP outcomes?

Review article published in the Journal of Endourology. Dr. El Tayeb looked at this in 2015 and did not find any difference.

I haven’t figured out yet why some dissections are more difficult than others. I do think that the older men that I operate on have poorer tissue quality and thus the “surgical capsule” is not as robust. In these cases, I find that I do not stay in my correct plane as often. When I get out of the correct plane, I spend more time cutting through tissue  and also correcting my mistakes. I think that this prolongs my enucleation time.

Maintaining the correct plane is also more difficult in small prostates (enucleations < 10-15 grams). The value of HoLEP in these settings is debatable and a conversation for another day. In my opinion, I still think that it does.

http://online.liebertpub.com/doi/abs/10.1089/end.2017.0734

@marawaneltayeb

fexapotide, injectable medication for BPH

http://rdcu.be/GxI4

phase 3 clinical trial on a new injectable medication for BPH. the medication had a reduced need for BPH intervention and acute urinary retention.

Sounds exciting!

Will have to review this paper further to look at improvement in symptom scores, which appear modest at first glance, as well as quantitative measures of improvement like flow rate.